Clinical and morphological aspects of low-temperature storage of malignant tumors (pilot study)
Ключевые слова:
malignant tumors, cryopreservation, tumor morphology, anticancer vaccinesАннотация
Probl Cryobiol Cryomed. 2026;36(1):40—49
Библиографические ссылки
Baatz JE, Newton DA, Riemer EC, et al. Cryopreservation of viable human lung tissue for versatile post-thaw analyses and culture. In Vivo. 2014; 28(4): 411-23. PubMed
Baust JM, Santucci KL, Van Buskirk RG, et al. An in vitro investigation into cryoablation and adjunctive cryoablation/chemotherapy combination therapy for the treatment of pancreatic cancer using the PANC-1 cell line. Biomedicines. 2022; 10(2): 450. CrossRef
Bol KF, Aarntzen EH, Hout FE, et al. Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination. OncoImmunology [Internet]. 2015 Jun 5 [cited 2025 Aug 30]; 5(1): e1057673. Available from: https://www.tandfonline.com/doi/full/10.1080/2162402X.2015.1057673 CrossRef
Boudewijns S, Bloemendal M, Gerritsen WR, et al. Dendritic cell vaccination in melanoma patients: From promising results to future perspectives. Hum Vaccin Immunother. 2016; 12(10): 2523-8. CrossRef
Chen S, Huang X, Xue Y, et al. Nanotechnology-based mRNA vaccines. Nat Rev Methods Primers [Internet]. 2023 Aug 17 [cited 2023 Aug 30]; 3(1): 63. Available from: https://www.nature.com/articles/s43586-023-00246-7 CrossRef
Chiang CL-L, Coukos G, Kandalaft LE. Whole tumor antigen vaccines: where are we? Vaccines (Basel). 2015; 3(2): 344-72. CrossRef
Diken M, Kranz LM, Kreiter S, Sahin U. mRNA: A versatile molecule for cancer vaccines. Curr Issues Mol Biol. 2017; 22(1): 113-28. CrossRef
Don A, Nagay S, Sadikova D. Assessment of morphological changes in the thyroid gland by test-point method with the introduction of dipsacoside. Astana Med J. 2022; S1: 181-6. CrossRef
Ghorbaninezhad F, Asadzadeh Z, Masoumi J, et al. Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside. Life Sci [Internet]. 2022 May 15 [cited 2022 Mar 7]; 297:120466. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0024320522001667 CrossRef
Goltsev AM, Gaevska YO, Dubrava TG, et al. Cryolysate of tumor cells: from technology of its obtaining up to creation of anti-cancer vaccines. Probl Cryobiol Cryomed. 2024; 34(3): 226-35. CrossRef
Hailemichael Y, Woods A, Fu T, et al. Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. J Clin Invest. 2018; 128(4): 1338-54. CrossRef
Hato L, Vizcay A, Eguren I, et al. Dendritic cells in cancer immunology and immunotherapy. Cancers [Internet]. 2024 Feb 28 [cited 2025 Mar 7]; 16(5): 981. Available from: https://www.mdpi.com/2072-6694/16/5/981 CrossRef
Huang X, Jiang J , Shen J, et al. The influences of cryopreservation methods on RNA, protein, microstructure and cell viability of skeletal muscle tissue. Biopreserv Biobank. 2024; 22(3): 225-34. CrossRef
Kelly R, Albert M, de Ladurantaye M, et al. RNA and DNA integrity remain stable in frozen tissue after long-term storage at cryogenic temperatures: a report from the Ontario Tumour Bank. Biopreserv Biobank. 2019; 17(4): 282-7. CrossRef
Khranovska NM, Kryachok IA, Ganul VL, et al. [Elaboration, rationale and clinical benefit of antitumor vaccine therapy based on dendritic cells for patients with malignant neoplasms]. Clin Oncol. 2014; 2(14): 62-9. Ukrainian.
Korpan NN, Goltsev AN, Dronov OI, et al. Cryoimmunology: opportunities and challenges in biomedical science and practice. Cryobiology. 2021; 100: 1-11. CrossRef
Kuzmenko AP, Didenko GV, Shpak GE, Potebnya GP. [Comparative evaluation of the antitumor efficacy of allogeneic and xenogeneic vaccine modified by protein metabolites of B. subtilis B-7025]. Clin Oncol. 2014; 4 (16): 90-4. Ukrainian.
Lin MJ, Svensson-Arvelund J, Lubitz GS, et al. Cancer vaccines: the next immunotherapy frontier. Nat Cancer. 2022; 3(8): 911-26. CrossRef
Liu X, Zhang Y, Zhou S, et al. Circular RNA: an emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines. J Control Release. 2022; 348: 84-94. CrossRef
Najafi S, Mortezaee K. Advances in dendritic cell vaccination therapy of cancer. Biomed Pharmacother [Internet]. 2023 Aug [cited 2023 May 29]; 164: 114954. Available from: https://www.sciencedirect.com/science/article/pii/S0753332223007448 CrossRef
Panov S. [The morphological specifics of the stromal and parenchymal liver components of 6-12- months old children from HIV-mono-infected mothers.] Actual Problems of Modern Medicine. 2021; (7): 53-63. Ukrainian. CrossRef
Qin X, Yang T, Xu H, et al. Dying tumor cells-inspired vaccine for boosting humoral and cellular immunity against cancer. J Control Release. 2023; 359: 359-72. CrossRef
Şahin U, Derhovanessian E, Miller M, et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature. 2017; 547 (7662): 222-6. CrossRef
Şahin U, Türeci Ö. Personalized vaccines for cancer immunotherapy. Science. 2018; 359(6382): 1355-60. CrossRef
Santucci KL, Snyder KK, Van Buskirk RG, et al. Investigation of lung cancer cell response to cryoablation and adjunctive gemcitabine-based cryo-chemotherapy using the A549 cell line. Biomedicines. 2024; 2024 Jun 3 [cited 2025 Jan 27]; 12(6): 1239. Available from: https://www.mdpi.com/2227-9059/12/6/1239 CrossRef
Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024; 74(1): 12‐49. CrossRef
Weber JS, Carlino MS, Khattak A, et al. Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study. The Lancet. 2024; 403(10427): 632-44. CrossRef
Xie N, Shen G, Gao W, et al. Neoantigens: promising targets for cancer therapy. Sig Transduct Target Ther [Internet]. 2023 Jan 06 [cited 2023 Jan 27] 8(1):9. Available from: https://www.nature.com/articles/s41392-022- 01270-x CrossRef
Yaremenko AV, Khan MM, Zhen X, et al. Clinical advances of mRNA vaccines for cancer immunotherapy. Med [Internet]. 2025 Jan 10; 6(1): 100562. Available from: https://www.sciencedirect.com/science/article/pii/S2666634024004562 CrossRef
Zhang, Y., Liu, X., Shen, T. et al. Small circular RNAs as vaccines for cancer immunotherapy. Nat Biomed Engineering. 2025; 9(2): 249-67. CrossRef
Загрузки
Опубликован
Как цитировать
Выпуск
Раздел
Лицензия
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Авторы, публикующие в данном журнале, соглашаются со следующим:
- Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License, которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в этом журнале.
- Авторы сохраняют право заключать отдельные контрактные договоренности, касающиеся не-эксклюзивного распространения версии работы в опубликованном здесь виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию в этом журнале.
- Авторы имеют право размещать их работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу (См. The Effect of Open Access).
